Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$733
|
$693B |
12.3x |
29.4x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$177
|
$459B |
5.0x |
13.6x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$210
|
$436B |
7.4x |
16.1x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 262
|
$284B |
3.7x |
9.4x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£118
|
$271B |
4.7x |
13.5x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 101
|
$268B |
4.9x |
11.9x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 359
|
$260B |
5.4x |
11.0x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$84
|
$237B |
3.7x |
8.3x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$288
|
$203B |
5.8x |
10.9x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$188B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$113
|
$160B |
5.6x |
11.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$47
|
$133B |
2.8x |
9.3x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€84
|
$128B |
2.4x |
8.2x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£15
|
$96.9B |
2.3x |
6.7x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$391
|
$95.4B |
8.2x |
24.5x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$156
|
$74.7B |
7.9x |
18.2x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4421
|
$74.6B |
2.4x |
9.3x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$69.9B |
1.3x |
6.2x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 6509
|
$65.3B |
8.0x |
15.9x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€108
|
$63.8B |
2.6x |
9.1x |
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$447
|
$57.0B |
18.6x |
123.3x |
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$581
|
$56.8B |
4.1x |
11.5x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 66
|
$56.3B |
12.8x |
44.4x |
Haleon
|
United Kingdom of Great Britain and Northern Ireland |
Health & Beauty,
Drug Development & Therapeutics
|
£4
|
$54.1B |
3.6x |
14.5x |
Fresenius
|
Germany |
Hospitals & Clinics,
Medical Supplies,
Drug Development & Therapeutics
|
€46
|
$43.7B |
1.7x |
10.2x |
Galderma Group
|
Switzerland |
Health & Beauty,
Drug Development & Therapeutics
|
CHF 140
|
$42.9B |
8.7x |
37.9x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 3529
|
$41.4B |
3.1x |
14.9x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1595
|
$41.1B |
6.6x |
23.2x |
argenx
|
Belgium |
Drug Development & Therapeutics
|
€604
|
$39.1B |
11.1x |
58.8x |
BeOne Medicines
|
Hong Kong |
Drug Development & Therapeutics
|
HKD 193
|
$36.4B |
7.6x |
354.2x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 60
|
$35.3B |
2.1x |
7.3x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 50
|
$31.0B |
2.8x |
13.4x |
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$136
|
$27.5B |
63.1x |
-28.2x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.2B |
1.9x |
6.1x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 7766
|
$26.1B |
1.6x |
6.9x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1620
|
$23.8B |
1.8x |
8.8x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$23.6B |
12.3x |
32.9x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$132
|
$23.2B |
2.4x |
7.1x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 10
|
$22.5B |
2.3x |
6.6x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 97
|
$20.5B |
13.1x |
188.1x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 335
|
$18.7B |
40.5x |
138.3x |
Divi's Laboratories
|
India |
Contract Research & Manufacturing,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 6132
|
$18.2B |
16.1x |
50.0x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€11
|
$18.0B |
2.1x |
8.5x |
Zhangzhou Pientzehuang
|
China |
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
CNY 209
|
$17.5B |
11.3x |
32.8x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 156
|
$17.5B |
41.9x |
-1673.5x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$17.5B |
4.0x |
15.7x |
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$24
|
$17.3B |
N/A |
-50.9x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€53
|
$15.0B |
5.1x |
13.6x |
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$85
|
$14.1B |
3.1x |
14.2x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3560
|
$14.1B |
10.1x |
31.0x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1590
|
$13.5B |
4.2x |
16.6x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$13.4B |
3.3x |
12.4x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$140
|
$13.3B |
5.0x |
20.9x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 27
|
$13.0B |
2.2x |
14.3x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 454
|
$12.9B |
47.7x |
-332.3x |
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$12.8B |
2.8x |
14.5x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 1588
|
$12.5B |
3.5x |
9.5x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2471
|
$12.4B |
8.1x |
32.1x |
Ascendis Pharma
|
Germany |
Drug Development & Therapeutics
|
€166
|
$12.0B |
N/A |
N/A |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1263
|
$11.8B |
3.1x |
12.0x |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.7B |
0.3x |
5.3x |
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$128
|
$11.5B |
2.8x |
9.8x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 287
|
$11.5B |
4.0x |
11.0x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€68
|
$11.3B |
5.8x |
18.4x |
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$52
|
$11.0B |
28.4x |
-23.8x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2550
|
$11.0B |
3.5x |
8.8x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 981
|
$10.8B |
3.9x |
13.6x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$10.7B |
1.7x |
5.5x |
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$305
|
$10.7B |
3.4x |
6.5x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€116
|
$10.5B |
2.5x |
7.0x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 44
|
$10.4B |
1.7x |
13.3x |
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$58
|
$10.4B |
3.4x |
12.2x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1893
|
$10.2B |
3.7x |
15.5x |
Caliway Biopharmaceuticals
|
Taiwan |
Drug Development & Therapeutics
|
TWD 202
|
$10.0B |
8461.2x |
-314.1x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$73
|
$9.5B |
7.8x |
12.0x |
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$37
|
$9.5B |
4.2x |
11.8x |
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$438
|
$9.1B |
14.2x |
-28.1x |
Haisco Pharmaceutical
|
China |
Drug Development & Therapeutics
|
CNY 55
|
$8.8B |
14.9x |
83.7x |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4538
|
$8.3B |
1.6x |
12.6x |
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$100
|
$8.0B |
3.0x |
-5.6x |
Kelun
|
China |
Drug Development & Therapeutics,
Medical Supplies
|
CNY 36
|
$7.8B |
2.6x |
11.7x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 39
|
$7.7B |
N/A |
N/A |
Salubris Pharmaceuticals
|
China |
Drug Development & Therapeutics,
Medical Devices
|
CNY 50
|
$7.7B |
12.7x |
39.4x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2545
|
$7.4B |
2.3x |
9.9x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 31498
|
$7.3B |
9.6x |
35.6x |
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$70
|
$7.0B |
8.7x |
N/A |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5304
|
$7.0B |
4.5x |
22.9x |
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$14
|
$6.9B |
N/A |
N/A |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1028
|
$6.8B |
1.8x |
8.9x |
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$103
|
$6.7B |
40.0x |
-32.7x |
Shanghai Allist
|
China |
Drug Development & Therapeutics
|
CNY 114
|
$6.6B |
10.5x |
30.0x |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£18
|
$6.6B |
2.0x |
7.6x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 30
|
$6.6B |
1.6x |
8.3x |
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$24
|
$6.5B |
1.5x |
8.6x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1924
|
$6.3B |
3.9x |
21.0x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€201
|
$6.3B |
2.7x |
10.0x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 113339
|
$6.1B |
3.9x |
53.3x |
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€69
|
$6.0B |
523.1x |
-30.2x |
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$121
|
$6.0B |
11.0x |
-33.8x |
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$5.9B |
7.3x |
-14.4x |